Articles Archives - Page 84 of 746

ThursdaySep 26, 2024 10:30 am

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) Looking to Seize Opportunities in Growing Battery-Minerals, Gold Sectors

The dual focus on battery minerals and gold presents unique opportunities and challenges for Canada-based mining companies. Renforth Resources is emerging as a noteworthy player in both the gold and battery-mineral spaces. The company is actively advancing efforts through exploration activities. Canada has long been recognized as a mining powerhouse, with its vast natural resources playing a crucial role in the economy. Among these resources, gold and battery minerals are gaining prominence as global demand surges. Renforth Resources (CSE: RFR) (OTCQB: RFHRF) is an active mineral-exploration company engaged in mining’s growing exploration and development space. The rise in electric-vehicle production…

ThursdaySep 26, 2024 9:45 am

420 Expo: New Jersey’s Largest Consumer Cannabis Convention Ends the Summer Season with 3-Days of Industry ‘Edutainment’; Announces Winners of the First-Ever Legal Statewide Cannabis Cup

The 420 Expo (https://www.420expo.com/) recently concluded its third annual three-day event series with over 14,000 cannabis enthusiasts making their way to the New Jersey Convention and Exposition Center, in Edison, September 13-15, 2024. Presented by Wakit Grinders (https://wakitgrinders.com), the B.Y.O.C. (bring your own cannabis) public event featured access to a large variety of cannabis-friendly vendors and dispensaries, cultivators, CBD businesses, accessories, and beverages, clothing and apparel, jewelry, art, food trucks, celebrity guests, glass blowers and lots of other brands and products. Guests had the opportunity to attend a variety of seminars and engage with canna-focused nonprofits and advocacy groups, as…

ThursdaySep 26, 2024 9:00 am

DGE’s 5th Human Factors Engineering and Usability Studies Congress Discusses Ways of Improving User Experience

DGE’s 5th Human Factors Engineering & Usability Studies Congress will be held October 23-24, 2024, in Philadelphia, PA. A live-streaming option is also available. Experts across the pharma, medical device and healthcare spectrum will share the latest insights on improving user experience through innovative designs of Medical Devices, IFUs and Combination Products, while maintaining regulatory compliance and cross-functional team performance. The summit is hosted by Dynamic Global Events (“DGE”), an event company that organizes B2B events for life science companies. DGE offers the members of the biopharma, healthcare, technology, engineering, and medical device industries, a robust forum for discussion and…

WednesdaySep 25, 2024 11:15 am

Dynasty Gold Corp. (TSX.V: DYG) (OTC: DGDCF) Thundercloud Drilling Reveals Up to 24.53 g/t High-Grade Gold Intercepts

The initial phase of the 2024 drilling program, held in July, hit multiple high-grade intercepts over 2,198 meters at the company’s flagship Thundercloud property in Ontario. Assay results confirmed the high-grade mineralization discovered in 2022 and 2023 to the east of the Pelham Zone, and the presence of a strong gold system on the property. Consistent high-grade mineralization was intercepted, between 5 to 8+ g/t and going as high as 24.53 g/t, at less than 100 meters below the surface. The fall drilling campaign is set to commence before the end of September. Dynasty (TSX.V: DYG) (OTC: DGDCF), a Canadian…

WednesdaySep 25, 2024 10:30 am

Into Nightfood Holdings Inc.’s (NGTF) Hands: California Hospitality Companies Employ Automation in Fight for Survival Resulting from Hourly Wage Increase

California's recent minimum wage hike to $20 per hour has already driven many restaurants out of business Nightfood Holdings is capitalizing on this shift by diversifying with the acquisition of Future Hospitality Ventures Future Hospitality Ventures is an early entrant in the burgeoning Robotics-as-a Service market as billions of dollars shift from labor to automation in the coming years The recent and unprecedented increase in California's minimum wage for foodservice workers has forced every restaurant and hospitality business statewide to evaluate their future existence and viability. Acquisition and development company Nightfood Holdings (OTCQB: NGTF), a pioneer in the sleep-friendly nighttime…

WednesdaySep 25, 2024 9:45 am

SOBRsafe Inc. (NASDAQ: SOBR) Experiencing New Growth After Entering the Behavioral Health Market

SOBRsafe, developer of advanced alcohol detection and monitoring technology, has, after its recent expansion into the behavioral health market, already secured 35 new customer accounts year-to-date The company recently unveiled a national campaign targeting more than 45,000 behavioral health decision makers across the country The campaign is now expected to significantly build the SOBRsafe brand, grow demand and increase the company’s market share SOBRsafe (NASDAQ: SOBR), the developer of advanced transdermal alcohol detection and monitoring technology, has made substantial progress in 2024. The company has secured 35 new customer accounts this year, a substantial increase over 2023. The success followed…

WednesdaySep 25, 2024 9:00 am

Annovis Bio Inc. (NYSE: ANVS) Presented Recent Achievements and Strategic Direction at H.C. Wainwright Investment Conference

The event was attended by Annovis Founder, President and CEO Maria L. Maccecchini, Ph.D. Dr. Maccecchini discussed the company’s notable achievements and plans for the future and held a Q&A session with attendees. The company CEO also participated in an expert panel discussing innovative non-amyloid approaches in Alzheimer’s disease. Recent clinical trials of the company’s lead compound buntanetap obtained encouraging results and was shown to improve cognition in both Alzheimer’s and Parkinson’s patients. Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), participated in…

TuesdaySep 24, 2024 11:15 am

DGE’s 3rd Chief Commercial Officer Summit to Provide Out-Of-Box Strategies for Driving Commercial Growth

The Chief Commercial Officer Summit, organized by Dynamic Global Events (“DGE”), returns to Philadelphia, PA, this fall. The 3rd Chief Commercial Officer Summit is scheduled for October 23-24, 2024, taking on a hybrid format. The in-person event is being held at The Inn at Penn – Hilton Hotel, conveniently located just six miles from the Philadelphia International Airport. Organizers will also be streaming the event live to a virtual audience, with the online option also allowing attendees to follow the sessions whenever and wherever on demand. The 3rd Chief Commercial Officer Summit is expected to bring together leaders and professionals…

TuesdaySep 24, 2024 10:30 am

Finovate Awards: Announced at the FinovateFall Congratulates Winners

The Finovate platform showcases innovations, technologies and new applications to an audience consisting of senior executives, experts, financial institutions, credit unions, and VCs, from all across the globe. Every demo hosted by fintech companies demonstrates unique innovations, technology and products. Finovate events are meticulously curated conferences for and by executives of the fintech spectrum. Thousands of executives, companies and investors from around the globe attend the conferences to learn the latest trends and technology in the fintech world. These visionaries offer sharp insights and strategies on the important aspects of the industry. Upcoming and established companies/individuals are selected by the…

TuesdaySep 24, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) to Discuss Lead Candidate CNM-Au8(R) Biomarker, Clinical Data for ALS with Food and Drug Administration Leadership

The company is seeking an accelerated approval regulatory pathway for CNM-Au8® for ALS. The FDA agreed to an in-person meeting to reevaluate Clene’s submission. Lead drug candidate CNM-Au8 has been shown to restore and protect neurological function, offering hope for patients with neurodegenerative conditions. The FDA meeting will be held before the end of November and will be attended by top FDA officials and key opinion leaders in ALS, biostatistics and biomarkers. Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative…

Site Search

Company Search

Category: Articles